Follow
Francisco J Tinahones
Francisco J Tinahones
University of Málaga. IBIMA
Verified email at uma.es
Title
Cited by
Cited by
Year
Benefits of polyphenols on gut microbiota and implications in human health
F Cardona, C Andrés-Lacueva, S Tulipani, FJ Tinahones, ...
The Journal of nutritional biochemistry 24 (8), 1415-1422, 2013
13632013
Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance
JM Moreno-Navarrete, F Ortega, M Serrano, E Guerra, G Pardo, ...
The Journal of Clinical Endocrinology & Metabolism 98 (4), E769-E778, 2013
8562013
Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study
M Murri, I Leiva, JM Gomez-Zumaquero, FJ Tinahones, F Cardona, ...
BMC medicine 11, 1-12, 2013
7272013
Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers
MI Queipo-Ortuño, M Boto-Ordóñez, M Murri, JM Gomez-Zumaquero, ...
The American journal of clinical nutrition 95 (6), 1323-1334, 2012
6642012
Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11. 2 locus
S Jacquemont, A Reymond, F Zufferey, L Harewood, RG Walters, ...
Nature 478 (7367), 97-102, 2011
4902011
Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels
MI Queipo-Ortuño, LM Seoane, M Murri, M Pardo, JM Gomez-Zumaquero, ...
PloS one 8 (5), e65465, 2013
4602013
Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation
P Pérez-Martínez, DP Mikhailidis, VG Athyros, M Bullo, P Couture, ...
Nutrition reviews 75 (5), 307-326, 2017
3272017
Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus
I Moreno-Indias, F Cardona, FJ Tinahones, MI Queipo-Ortuño
Frontiers in microbiology 5, 190, 2014
3072014
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study
KK Ray, B Molemans, WM Schoonen, P Giovas, S Bray, G Kiru, J Murphy, ...
European journal of preventive cardiology 28 (11), 1279-1289, 2021
2892021
Red wine polyphenols modulate fecal microbiota and reduce markers of the metabolic syndrome in obese patients
I Moreno-Indias, L Sánchez-Alcoholado, P Pérez-Martínez, ...
Food & function 7 (4), 1775-1787, 2016
2572016
Thrombosis in primary antiphospholipid syndrome. A pivotal role for monocyte tissue factor expression
MJ Cuadrado, C López‐Pedrera, MA Khamashta, MT Camps, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1997
2571997
Executive functions profile in extreme eating/weight conditions: from anorexia nervosa to obesity
AB Fagundo, R De la Torre, S Jiménez-Murcia, Z Agüera, R Granero, ...
Public Library of Science 7 (8), e43382, 2012
2462012
Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus
F Soriguer, L Garrido-Sanchez, S Garcia-Serrano, JM Garcia-Almeida, ...
Obesity surgery 19, 1574-1580, 2009
2422009
Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index
M Pardo, AB Crujeiras, M Amil, Z Aguera, S Jiménez-Murcia, R Baños, ...
International journal of endocrinology 2014, 2014
2382014
Hypertension is related to the degradation of dietary frying oils
F Soriguer, G Rojo-Martínez, MC Dobarganes, JM García Almeida, ...
The American journal of clinical nutrition 78 (6), 1092-1097, 2003
2302003
Two healthy diets modulate gut microbial community improving insulin sensitivity in a human obese population
C Haro, M Montes-Borrego, OA Rangel-Zúñiga, JF Alcalá-Díaz, ...
The Journal of Clinical Endocrinology 101 (1), 233-242, 2016
2282016
Lifetime obesity in patients with eating disorders: increasing prevalence, clinical and personality correlates
C Villarejo, F Fernández‐Aranda, S Jiménez‐Murcia, E Peñas‐Lledó, ...
European Eating Disorders Review 20 (3), 250-254, 2012
2152012
Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota
C Serena, V Ceperuelo-Mallafré, N Keiran, MI Queipo-Ortuño, R Bernal, ...
The ISME journal 12 (7), 1642-1657, 2018
2092018
Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial
B Ludvik, JP Frías, FJ Tinahones, J Wainstein, H Jiang, KE Robertson, ...
The lancet Diabetes & endocrinology 6 (5), 370-381, 2018
2052018
The obese healthy paradox: is inflammation the answer?
N Barbarroja, R Lopez-Pedrera, MD Mayas, E Garcia-Fuentes, ...
Biochemical Journal 430 (1), 141-149, 2010
2032010
The system can't perform the operation now. Try again later.
Articles 1–20